[T]he pharmaceutical industry has been extremely reticent to explore this.

There is clear evidence that the symptoms of some patients who have been exposed to finasteride are unexplained, and the pharmaceutical industry has been extremely reticent to explore this. Add in relational difficulties plus premature hair loss and you could have a perfect storm to make some people more vulnerable.

The Telegraph: May 22, 2024